Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
[3H]Dopamine ([3H]DA) Uptake Assay from US Patent US11999676: "Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse"
Assay data:47 Active, 47 Activity ≤ 1 µM, 47 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
[3H]Dihydrotetrabenazine ([3H]DTBZ) Binding Assay from US Patent US11999676: "Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse"
Assay data:49 Active, 18 Activity ≤ 1 µM, 53 Tested
[3H]DA and [3H]5-HT Uptake Assay from US Patent US11999676: "Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse"
Assay data:90 Active, 90 Activity ≤ 1 µM, 91 Tested
Competition Binding in Human 5-HT2A Receptor from US Patent US20240166639: "POTENT AND SELECTIVE COMPOUNDS AS SEROTONIN 1B RECEPTOR MODULATORS"
Assay data:12 Active, 5 Activity ≤ 1 µM, 17 Tested
Inhibition Assays of Transporters (hSERT and rVMAT2) from US Patent US20240150372: "OXA-IBOGAINE ANALOGUES FOR TREATMENT OF SUBSTANCE USE DISORDERS"
Assay data:3 Active, 2 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
In Vitro Activity Assay from US Patent US11944616: "Dizocilpine derivatives as peripheral NMDA receptor antagonists"
Assay data:10 Active, 9 Activity ≤ 1 µM, 10 Tested
Fluorescent Polarization (FP) ASGPR Binding Assay from US Patent US20240092819: "NOVEL LIGANDS FOR ASIALOGLYCOPROTEIN RECEPTOR"
Assay data:6 Active, 5 Activity ≤ 1 µM, 29 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µM
Inhibitory Activity Against KHK In Vitro from US Patent US20240067633: "KETOHEXOKINASE INHIBITOR AND USE THEREOF"
Assay data:9 Active, 9 Activity ≤ 1 µM, 9 Tested
Steroid Inhibition of TBPS Binding from US Patent US11912737: "19-nor neuroactive steroids and methods of use thereof"
Assay data:4 Active, 47 Activity ≤ 1 µM, 47 Tested
DHODH Kinetic Analysis from US Patent US11903936: "Anti-malarial agents"
Assay data:13 Active, 13 Activity ≤ 1 µM, 13 Tested
Biochemical Rat MASP2 Assay from US Patent US20240010684: "MASP INHIBITORY COMPOUNDS AND USES THEREOF"
Assay data:20 Active, 20 Activity ≤ 1 µM, 20 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Depositor
Biochemical Rat MASP1 Assay from US Patent US20240010684: "MASP INHIBITORY COMPOUNDS AND USES THEREOF"
Assay data:21 Active, 21 Activity ≤ 1 µM, 21 Tested
Steroid Inhibition of TBPS Binding from US Patent US20230322846: "NEUROACTIVE STEROIDS AND THEIR METHODS OF USE"
Assay data:315 Active, 255 Activity ≤ 1 µM, 326 Tested
NR2B Antagonist Activity from US Patent US11752155: "Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders"
Assay data:56 Active, 11 Activity ≤ 1 nM, 57 Activity ≤ 1 µM, 57 Tested
Radioligand Binding Assay on Rat TAAR1 from US Patent US11697636: "Substituted benzamides"
Assay data:313 Active, 31 Activity ≤ 1 nM, 305 Activity ≤ 1 µM, 314 Tested
Competitive Radioligand Binding Assay from US Patent US11691947: "Isoindoline compositions and methods for treating neurodegenerative disease"
Assay data:81 Active, 3 Activity ≤ 1 nM, 79 Activity ≤ 1 µM, 93 Tested
Binding to Nicotinic Receptor Subtypes from US Patent US11667638: "4-substitued cytisine analogues"
Assay data:50 Active, 3 Activity ≤ 1 nM, 50 Activity ≤ 1 µM, 50 Tested
Determination of Ki Value at Human and Rat Histamin-3 Receptor from US Patent US11622967: "Method of treatment with histamine-3 receptor inverse agonist"
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Dopamine D2L Receptor Binding Assay from US Patent US11576897: "Therapeutic agent for non-motor symptoms associated with Parkinson's disease"
Assay data:5 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Serotonin Transporter Binding Assay from US Patent US11555013: "Potent and selective inhibitors of monoamine transporters; method of making; and use thereof"
Assay data:27 Active, 13 Activity ≤ 1 µM, 52 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on